| Name | Title | Contact Details |
|---|
Volpara Health provides an advanced AI software platform that enables a high-quality, optimized and personalized cancer screening experience. From the time a patient enters a clinic to the moment they obtain key results, the Volpara Breast Health Platform collects and analyzes information to better understand a patient`s breast cancer risk, while also objectively evaluating image quality and workflow-improvement opportunities. More than thirteen million women across 39 countries have had their breast density assessed by Volpara. The company`s software is installed in approximately 2000 leading facilities worldwide, including top cancer centers in the United States. Volpara Health`s technology has been the subject of more than 300 publications. The Volpara Breast Health Platform is supported by numerous patents, trademarks, and regulatory registrations, including FDA clearance and CE marking.
Hand & Stone is a 550-plus unit massage and facial spa franchise with a mission to bring affordable, luxury spa services to all. Launched in 2004, the company now has locations across 35 states and Canada. Hand & Stone offers its signature hot stone massage, along with other high-quality professional massage services such as Swedish, Himalayan Salt, Sports, Deep Tissue, Oncology and Prenatal. Guests can also visit the spa to enjoy best-in-class facial treatments performed by licensed estheticians. These feature top-of-the-line products backed by science, including Dermalogica and ClarityRx Clinical Skin Care. A wide range of services are available for women, men and teens and are tailored to each individual`s needs or skin concerns. The fastest-growing spa franchise in the country, Hand & Stone has been named No. 1 in the spa category by Entrepreneur Magazine in 2023, 2021 and 2020 and was ranked No. 8 on Forbes` Best Franchises to Buy list in the high investment category.
Find a barre3® studio near you or subscribe to barre3 Online and start an online workout today.
Unlike traditional approaches that only address symptoms, Cardionomic addresses the conditions root cause of reduced contractility. The therapy uses neuromodulation to benignly increase contractility, thus improving cardiac output therefore increasing renal flow and end organ perfusion. Benignly increasing contractility decreases negative hormonal signaling, and improves in-hospital morbidity/mortality. This breakthrough therapy is also expected to increase pharmacological tolerance at discharge, which will reduce costly readmission and extend life. Spun off from Denali Medical II, a New Enterprise Associates (NEA) backed incubator, Cardionomic is funded by NEA, Greatbatch Medical and Cleveland Clinic Foundation.
CRB Engineers, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Kansas City, MO. To find more information about CRB Engineers, Inc., please visit www.crbusa.com